SC 13D Filing

Company

Cardiff Oncology, Inc.

Filed

April 5, 2016

Accession Number

0000895345-16-000455

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →